Drug Pricing Transparency Act
I also today voted to support a bill that addresses the skyrocketing prices of prescription drugs. The Prescription Drug Pricing Transparency Act requires price transparency for three categories of drugs: existing drugs, new drugs and newly acquired drugs. Manufacturers would be required to report drug pricing information for drugs that exceed certain thresholds or increase by a certain percentage over a 12 or 24-month period. The Minnesota Department of Health would post this information on a public website in an easily accessible and clear format. Drug manufacturers are currently not subject to the same price transparency regulation as hospitals, providers and health plans.
Bottom line: prescription drugs don’t work if they aren’t affordable. We have more to do to bring down these prices, but this is a positive step forward for Minnesota.
Long-Term Care Strategy for our Senior Citizens
Our nursing homes and other congregate care settings have been among those impacted the worst by the COVID-19 pandemic. Everyone living and working in these facilities deserves to be safe and healthy, and they deserve to know we support them in our efforts to keep the virus at bay.
This week, Governor Tim Walz and Minnesota Department of Health Jan Malcolm released a new five-point plan to provide more robust support to our state’s long-term care facilities. The plan’s five points are: expanded testing for residents and workers; providing testing support and troubleshooting; getting needed personal protective equipment (PPE) to facilities; ensuring adequate staffing levels, and leveraging partnerships with local public health officials.
Keep in Touch
Please continue to reach out with questions or input.
Wishing you and your family a Happy Mother’s Day.